September 2, 2025 · Form 4 insider transaction
Moat Ross sold 481 shares of Kiniksa Pharmaceuticals Ltd. at $34.28 per share, a transaction worth $16.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.